英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

censurable    
a. 可非难的,该责备的

可非难的,该责备的

censurable
adj 1: deserving blame or censure as being wrong or evil or
injurious; "blameworthy if not criminal behavior";
"censurable misconduct"; "culpable negligence" [synonym:
{blameworthy}, {blamable}, {blameable}, {blameful},
{censurable}, {culpable}]

Censurable \Cen"sur*a*ble\, a.
Deserving of censure; blamable; culpable; reprehensible; as,
a censurable person, or censurable conduct. --
{Cen"sur*a*bleness}, n. -- {Cen"sur*a*bly}, adv.
[1913 Webster]


请选择你想看的字典辞典：
单词字典翻译
censurable查看　censurable　在百度字典中的解释百度英翻中〔查看〕
censurable查看　censurable　在Google字典中的解释Google英翻中〔查看〕
censurable查看　censurable　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Adstiladrin: Uses, Dosage, Side Effects Warnings - Drugs. com
    Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer Includes Adstiladrin side effects, interactions and indications
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
    Nadofaragene firadenovec- vncg (ADSTILADRIN) is A recommended treatment option: In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)* and the AUA SUO Guidelines1 By the International Bladder Cancer Group (IBCG) for high-risk NMIBC after BCG failure for those seeking to avoid radical cystectomy 2
  • ADSTILADRIN | FDA
    For the treatment of High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | NMIBC Treatment
    Adstiladrin is a prescription medicine for the treatment of adults with a type of cancer of the lining of the bladder called non-muscle invasive bladder cancer (NMIBC), that has not spread to other parts of the body, and that did not respond to treatment with Bacillus Calmette-Guérin (BCG)
  • Nadofaragene Firadenovec-vncg - NCI - National Cancer Institute
    Nadofaragene firadenovec-vncg is approved to treat: Non-muscle–invasive bladder cancer with carcinoma in situ It is used in adults whose cancer does not respond to treatment with bacillus Calmette-Guérin (BCG) and has a high risk of coming back Nadofaragene firadenovec-vncg is also being studied in the treatment of other types of cancer
  • Adstiladrin | European Medicines Agency (EMA)
    The full indication is: Adstiladrin is indicated as monotherapy for the treatment of adult patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours Adstiladrin will be available as a 3 x 10 11 viral particles ml intravesical suspension
  • Adstiladrin (Nadofaragene Firadenovec-vncg): Uses, Side . . .
    Adstiladrin (Nadofaragene Firadenovec-vncg) represents a significant advancement in the treatment of certain types of bladder cancer This innovative gene therapy is designed to address high-risk, non-muscle invasive bladder cancer (NMIBC) that has not responded to standard Bacillus Calmette-Guérin (BCG) therapy Understanding its mechanism, proper administration, and potential side effects
  • Ferring Announces Update to NCCN Guidelines Expanding . . .
    ADSTILADRIN ® (nadofaragene firadenovec-vncg) is an FDA-approved intravesical non-replicating gene-therapy for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors (±Ta T1)
  • Adstiladrin Bladder Cancer Treatment - The Urology Group Virginia
    Adstiladrin (nadofaragene firadenovec-vncg) is a medicine used to treat adults with a type of bladder cancer called high-risk non-muscle invasive bladder cancer (NMIBC) that has not responded to a treatment called BCG It is for patients who have carcinoma in situ (CIS), with or without small growths called papillary tumors How does Adstiladrin work? Adstiladrin is a gene therapy It uses a
  • BCAN - For Patients and Caregivers
    What is ADSTILADRIN? ADSTILADRIN (nadofaragene firadenovec-vncg) was approved in the United States in 2022 and is fully available for appropriate patients as a treatment that may help people live better lives on their bladder cancer journey ADSTILADRIN is a localized gene therapy designed to help the immune system fight NMIBC directly within the bladder Administered […]





中文字典-英文字典  2005-2009